I
IMNM
Immunome Inc
21.67
-0.79-3.52%After Hours: 21.80 +0.13 +0.60%19:56 04/10 EDT
OPEN/PREV CLOSE22.56/22.46
TODAY RANGE21.54-22.61
VOL1.14M
MARKET CAP2.45B
52 WEEK RANGE5.15-27.65
AVG VOL (3M)1.47M
% TURNOVER1.01%
TURNOVER--
P/E (TTM)-8.9122
% RANGE4.76%
EPS(TTM)-2.4315
P/E(FORWARD)-9.2213
P/B3.865
BVPS5.61
DIVIDEND--
P/S352.93
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.27B
SHARES OUTSTANDING113.13M
NEXT EARNINGS05/11-05/15
FREE FLOAT104.63M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1d ago
CANC: I Give A Hold Rating To This ETF That Invests In Cancer-Fighting Stocks
TipRanks·4d ago
Immunome (IMNM) Receives a Buy from LifeSci Capital
Reuters·04/03 23:48
Immunome CSO Jack Higgins disposes of $0.2 million common shares
Reuters·04/03 23:47
Immunome CFO Max Rosett disposes of common shares worth 1.4 million
Reuters·04/02 20:00
Immunome grants inducement stock options for 188,500 shares to 13 new hires
NASDAQ·04/01 11:56
Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last?
TipRanks·04/01 02:03
Top Biotech Boss Makes Bold Insider Move on Immunome Shares
Reuters·03/31 23:53
Immunome CEO Clay Siegall buys $0.5 million in common shares
NASDAQ·03/31 14:58
Tuesday 3/31 Insider Buying Report: NAVN, IMNM
TipRanks·03/13 02:01
Immunome Insider Quietly Boosts Stake in a Big Vote of Confidence
Reuters·03/12 10:10
Immunome Director Jean Jacques Bienaime Acquires Common Shares
Seeking Alpha·03/11 04:51
Immunome: Upcoming NDA, Valuation, And Investment Case
TipRanks·03/06 13:10
Analysts Are Bullish on Top Healthcare Stocks: MetaVia (MTVA), Immunome (IMNM)
Same Industry